Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.49)
# 268
Out of 5,064 analysts
586
Total ratings
51.2%
Success rate
21.62%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $14.67 | +36.33% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $1.24 | +303.23% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $474.82 | +5.30% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $175.30 | +10.67% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $11.29 | +6.29% | 18 | Jul 29, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $27 | $13.08 | +106.42% | 16 | Jul 11, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $4.55 | +405.49% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $66.04 | -9.15% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $23.56 | +35.82% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $426.76 | +28.88% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $198.76 | -39.63% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $5.56 | +43.88% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $4.92 | -59.35% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $29.11 | +20.23% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $10.48 | +33.59% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $29.34 | +19.29% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $4.27 | +227.87% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $34.32 | +118.53% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $70.56 | -3.63% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $21.18 | +79.41% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $17.39 | +43.76% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $18.00 | +77.78% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $6.97 | +330.42% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $13.64 | +17.30% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $11.52 | +108.33% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $3.00 | +300.00% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $94.04 | -59.59% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.08 | +284.62% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $141.83 | +18.45% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.57 | +600.64% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.34 | +646.27% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.05 | +212.06% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.84 | +137.16% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.06 | +482.52% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.62 | +181.39% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.75 | +62.96% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $7.26 | +216.80% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.96 | +1,457.96% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $95.76 | -11.24% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $23.28 | +50.34% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $12.01 | +524.48% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $42.44 | +76.72% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.44 | +186.89% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.70 | +112.77% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.83 | +18,081.82% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $16.38 | +266.30% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.96 | +202.42% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.16 | +3,348.28% | 3 | Mar 16, 2022 |
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $14.67
Upside: +36.33%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.24
Upside: +303.23%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $474.82
Upside: +5.30%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $175.30
Upside: +10.67%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $11.29
Upside: +6.29%
KalVista Pharmaceuticals
Jul 11, 2025
Reiterates: Buy
Price Target: $27
Current: $13.08
Upside: +106.42%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $4.55
Upside: +405.49%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $66.04
Upside: -9.15%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $23.56
Upside: +35.82%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $426.76
Upside: +28.88%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $198.76
Upside: -39.63%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $5.56
Upside: +43.88%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $4.92
Upside: -59.35%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $29.11
Upside: +20.23%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $10.48
Upside: +33.59%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $29.34
Upside: +19.29%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $4.27
Upside: +227.87%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $34.32
Upside: +118.53%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $70.56
Upside: -3.63%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $21.18
Upside: +79.41%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $17.39
Upside: +43.76%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $18.00
Upside: +77.78%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $6.97
Upside: +330.42%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $13.64
Upside: +17.30%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $11.52
Upside: +108.33%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $3.00
Upside: +300.00%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $94.04
Upside: -59.59%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.08
Upside: +284.62%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $141.83
Upside: +18.45%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.57
Upside: +600.64%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.34
Upside: +646.27%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $7.05
Upside: +212.06%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.84
Upside: +137.16%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.06
Upside: +482.52%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.62
Upside: +181.39%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $6.75
Upside: +62.96%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $7.26
Upside: +216.80%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $0.96
Upside: +1,457.96%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $95.76
Upside: -11.24%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $23.28
Upside: +50.34%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $12.01
Upside: +524.48%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $42.44
Upside: +76.72%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.44
Upside: +186.89%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $4.70
Upside: +112.77%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.83
Upside: +18,081.82%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $16.38
Upside: +266.30%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $4.96
Upside: +202.42%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.16
Upside: +3,348.28%